Who is sponsoring NCT03445247?

NCT03445247 is sponsored by Chang Gung Memorial Hospital.

What drugs are being tested in NCT03445247?

Interventions in NCT03445247: Extracorporeal low-intensity shockwave.

What condition does NCT03445247 study?

NCT03445247 studies Diabetic Nephropathy Type 2.

Is NCT03445247 still recruiting?

NCT03445247 is currently status unknown. Last updated 26 February 2018.

Last reviewed 2018-02-26 · How we verify

NCT03445247

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Extracorporeal Low-intensity Shockwave in Diabetic Nephropathy

Status unknown NA Last updated 26 February 2018

What this trial tests

NA trial testing Extracorporeal low-intensity shockwave in Diabetic Nephropathy Type 2 in 60 participants. Status unknown.

Timeline

1 July 2017

Primary endpoint
30 June 2019

30 June 2020

Quick facts

Lead sponsor	Chang Gung Memorial Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	60
Start date	1 July 2017
Primary completion	30 June 2019
Estimated completion	30 June 2020
Sites	1 location across Taiwan

Drugs / interventions tested

Extracorporeal low-intensity shockwave

Conditions studied

Diabetic Nephropathy Type 2 — all drugs for Diabetic Nephropathy Type 2 →

Sponsor

Chang Gung Memorial Hospital

Who can join

Adults 18 to 80, any sex, with Diabetic Nephropathy Type 2. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In the current study, we use extracorporeal low-intensity shockwave therapy (ESWT) to treat on patients with type 2 diabetes in stage 3-4 chronic kidney disease and see whether it can improve the proteinuria, renal function, and blood pressure compared to baseline and control group.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

It Comes As a Shock: Kidney Repair Using Shockwave Therapy.
Klomjit N, Lerman A, Lerman LO. · · 2020 · cited 11× · PMID 33131308 · DOI 10.1161/hypertensionaha.120.14595
Low-Intensity Extracorporeal Shockwave Therapy (LI-ESWT) in Renal Diseases: A Review of Animal and Human Studies.
Skov-Jeppesen SM, Petersen NA, Yderstraede KB, Jensen BL, et al · · 2023 · cited 3× · PMID 36778197 · DOI 10.2147/ijnrd.s389219

Verify or expand the search:

Other recruiting trials for Diabetic Nephropathy Type 2

Currently open trials in the same condition.

NCT06586203 — Clinical Utility of a Genomic Predictor Test on the Management of Cardiorenal Complications of Type 2 Diabetes · NA · recruiting
NCT05888909 — Multidimensional Accurate Diagnosis and Treatment Technology and Clinical Transformation of Type 2 Diabetes Nephropathy · recruiting
NCT06833541 — Research on Gut Microbiota and Metabolomics in Diabetic Kidney Disease · recruiting
NCT04931537 — Screening and Application Research of Early Diabetic Nephropathy Markers Based on Lipidomics. · recruiting
NCT04573920 — Atrasentan in Patients With Proteinuric Glomerular Diseases · Phase 2 · active not recruiting

Other Chang Gung Memorial Hospital trials

Trials by the same sponsor.

NCT07419789 — Precision Care for Older Persons · NA · not yet recruiting
NCT07248345 — Virtual Reality Intervention for Family Caregivers of Persons Living With Dementia · NA · not yet recruiting
NCT07036978 — Metabolomic and Immune-Microbiome Profiling for Unresectable Pancreatic Cancer · not yet recruiting
NCT07489833 — Metabolomic Pathways and Traditional Chinese Medicine Body Constitution in Cancer-related Fatigue · not yet recruiting
NCT07496528 — The ACURE Trial: Acupuncture for Colorectal Recovery · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03445247 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chang Gung Memorial Hospital
Last refreshed: 26 February 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03445247.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing